跳至主要内容
临床试验/EUCTR2009-016955-23-IT
EUCTR2009-016955-23-IT进行中(未招募)不适用

Assessment of association efficacy of colinergic precursor and cholinesterasic inhibitor somministered transdermal in patient with Alzheimer`s disease and severe behavioural disturbances - ASCOTALCO

AZIENDA USL 2 DI LUCCA0 个研究点开始时间: 2010年6月14日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - male / female age > 40 yrs - probable AD according to NINCDS-ADRDA criteria with BPSD e/o cognitive fluctuations e/o extra-pyramidal signs - Mini-Mental State Examination 14-pc-26 - patients never treated with ChEI or under treatment with ChEI no more than 2 yrs and now with rivastigmina patch 9,5 mg 1 patch/once a day for at last 2 months and no more than 12 months - subscription of informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Mini-Mental State Examination pc<14 or pc>26 - not controlled hearth, kidney or liver diseases - not controlled distyroidism - active oncologic diseases

研究者

发起方
AZIENDA USL 2 DI LUCCA

相似试验